COMMUNIQUÉS West-GlobeNewswire

Helsinn: Glenmark Pharmaceuticals expands its oncology franchise in India with the launch of Helsinn’s AKYNZEO®, a combination drug for the prevention of chemotherapy-induced nausea and vomiting (CINV)

10/07/2018 - 10:11

Glenmark Pharmaceuticals expands its oncology franchise in India with the launch of Helsinn’s AKYNZEO ® , a combination drug for the prevention of chemotherapy-induced nausea and vomiting (CINV) AKYNZEO ® was developed [...]

SPINEWAY : Implementation of the new strategic plan Signature of a financing agreement

10/07/2018 - 08:46

Implementation of the new strategic plan Signature of a financing agreement with Alpha Blue Ocean for a reserved issue of OCEANE (bonds convertible into new or existing shares) with attached warrants As announced on 13 [...]

SPINEWAY : Mise en place du nouveau plan stratégique signature d'un contrat de financement

10/07/2018 - 08:46

Mise en place du nouveau plan stratégique Signature d'un contrat de financement avec Alpha Blue Ocean par émission réservée d'OCEANE assorties de BSA Conformément à l'annonce du 13 juin 2018, SPINEWAY, spécialiste des [...]

Guerbet and IBM Watson Health Announce Strategic Partnership for Artificial Intelligence in Medical Imaging, Liver

10/07/2018 - 08:31

The agreement aims to develop and market software solutions to aid physicians' in their treatment recommendations and follow-up care for liver cancer. Villepinte (France) and Cambridge (USA) - July 10, 2018 (8:30 am [...]

Guerbet et IBM Watson Health annoncent un partenariat stratégique alliant l'intelligence artificielle à l'imagerie médicale

10/07/2018 - 08:31

L'accord vise à développer et commercialiser une solution logicielle d'aide au diagnostic et au suivi dans le cancer du foie. Villepinte (France) et Cambridge (Etats-Unis) - le 10 juillet 2018 (8:30 CEST) - Guerbet, [...]

Shire plc : Rule 2.9 announcement

10/07/2018 - 08:00

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 10 July 2018 Shire [...]

MediciNova Announces Clinical Data from Subgroup Analyses of Completed Clinical Trial of MN-166 (ibudilast) in ALS

10/07/2018 - 01:00

LA JOLLA, Calif., July 09, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875), [...]

Mesa Labs Declares Quarterly Dividend

10/07/2018 - 00:00

Lakewood, Colorado, July 09, 2018 (GLOBE NEWSWIRE) -- Mesa Laboratories, Inc. (NASDAQ:MLAB) (we, us, our, “Mesa” or the “Company”) today announced that its Board of Directors has declared a regular quarterly dividend of [...]

Helix BioPharma Corp. Closes Private Placement

09/07/2018 - 23:05

RICHMOND HILL, Ontario, July 09, 2018 (GLOBE NEWSWIRE) -- Helix BioPharma Corp. (TSX:HBP) (FSE:HBP) (“Helix” or the “Company”), an immuno-oncology company developing innovative drug candidates for the prevention and [...]

Adamas Announces New Employment Inducement Grant

09/07/2018 - 22:39

EMERYVILLE, Calif., July 09, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq:ADMS) today announced that the compensation committee of the company’s board of directors granted two new employees the option [...]

TRIO Awarded NATALEE Study, Largest Single Phase III Breast Cancer Clinical Trial in its History

09/07/2018 - 22:16

Ribociclib Combination Therapy in Adjuvant Setting Represents A Promising Therapy Against Breast Cancer EDMONTON, Alberta, July 09, 2018 (GLOBE NEWSWIRE) -- Translational Research In Oncology (TRIO) today announced a [...]

Actinium to Host Webcast on July 10, 2018 to Discuss Actimab-A MRD clinical trial for Minimal Residual Disease in Postremission AML Patients

09/07/2018 - 22:15

Minimal Residual Disease is increasingly recognized as a primary driver of high AML relapse with a need for improved consolidation therapies Webcast to be held on July 10, 2018 at 8:00 AM ET to discuss planned trial [...]

T2 Biosystems Reports Granting of Inducement Awards

09/07/2018 - 22:15

LEXINGTON, Mass., July 09, 2018 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), an emerging leader in the development and commercialization of innovative medical diagnostic products for critical unmet needs in [...]

Spero Therapeutics Announces Proposed Offering of Common Stock

09/07/2018 - 22:10

CAMBRIDGE, Mass., July 09, 2018 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (Nasdaq:SPRO) (Spero), a multi-asset clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel [...]

Inspire Medical Systems, Inc. Announces Aetna Coverage for Inspire Therapy for the Treatment of Obstructive Sleep Apnea

09/07/2018 - 22:01

MINNEAPOLIS, July 09, 2018 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE:INSP) ("Inspire”), a medical technology company focused on the development and commercialization of innovative and minimally invasive [...]

TLC Reports Last Patient Last Visit (LPLV) in TLC599 Phase II Trial and FDA Clearance to Commence New Clinical Trials

09/07/2018 - 21:01

LPLV marks the final steps toward completion of TLC599 trial for osteoarthritis (OA) pain Phase II topline results on-track for 2018 release Set to initiate enrollment of US Phase II pharmacokinetic (PK) trial for [...]

EnviroLogix Introduces QuickScan II

09/07/2018 - 18:59

EnviroLogix Inc.'s history as a technology innovator for the global agricultural diagnostic markets continues with the introduction of the next generation QuickScan II instrument for quantitative GMO and mycotoxin [...]

Sanofi: Disclosure of trading in own shares

09/07/2018 - 18:01

Attachment Disclosure of trading in own shares (pdf).pdf

Sanofi : Déclaration des transactions sur actions propres

09/07/2018 - 18:01

Pièce jointe Déclaration des transactions sur actions propres (pdf).pdf